Use of Drugs Associated with QT Interval Prolongation at the Hospital Level during the COVID-19 Pandemic in Colombia
Background. Many of the therapeutic proposals for COVID-19 have been associated with adverse effects, including the risk of QT interval prolongation and torsades de pointes (TdP). The objective was to determine the use of drugs with a risk of QT interval prolongation in 21 clinics/hospitals in Colom...
Saved in:
Main Authors: | Andrés Gaviria-Mendoza, Manuel Enrique Machado-Duque, Luis Fernando Valladales-Restrepo, Carlos Fernando Tovar-Yepes, Jorge Enrique Machado-Alba |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | International Journal of Vascular Medicine |
Online Access: | http://dx.doi.org/10.1155/2022/3045942 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of Tramadol or Other Analgesics in Patients Treated in the Emergency Department as a Risk Factor for Opioid Use
by: Jorge Enrique Machado-Alba, et al.
Published: (2020-01-01) -
Multifactorial QT Interval Prolongation and Takotsubo Cardiomyopathy
by: Michael Gysel, et al.
Published: (2014-01-01) -
Drugs that enlarge the QT interval of the electrocardiogram.
by: Pedro Miguel Milián Vázquez., et al.
Published: (2006-12-01) -
Potential QT-prolonging drug-drug interactions in cardiovascular disease patients
by: Milena Kovačević, et al.
Published: (2025-01-01) -
Bigeminy with Prolonged QT Interval as an Ominous Sign for Impending Torsades de Pointes: A Case Report
by: Thuc Vu, et al.
Published: (2024-11-01)